Form 4: Ceribell CTO Sells Shares After Option Exercise
Insider Transaction Report
Ceribell's Chief Technology Officer, Raymond Woo, executed a Rule 10b5-1 plan, exercising stock options and selling a portion of his common stock holdings.
Summary
- Raymond Woo, Chief Technology Officer of Ceribell, Inc. [CBLL], reported transactions on December 1, 2025, under a Rule 10b5-1 trading plan.
- Exercised stock options to acquire 1,472 shares of common stock at an exercise price of $2.24 per share.
- Exercised stock options to acquire 3,025 shares of common stock at an exercise price of $4.7 per share.
- Exercised stock options to acquire 6,615 shares of common stock at an exercise price of $4.7 per share.
- Sold a total of 11,112 shares of common stock at a weighted average price of $12.28 per share.
- The shares were sold in multiple transactions with prices ranging from $16.38 to $16.82 per share.
- Following these transactions, Raymond Woo beneficially owns 167,704 shares of common stock.
Sentiment
Score: 5
Explanation: The filing reports an insider's exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 trading plan. While an insider sale reduces direct equity exposure, it was planned and profitable for the individual, making the overall sentiment neutral regarding company performance.
Positives
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned rather than opportunistic sale.
- The sale price of $12.28 (weighted average) is significantly higher than the exercise prices of $2.24 and $4.7, indicating a profitable transaction for the insider.
Negatives
- An insider sale, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: May interpret the insider sale differently; some might see it as a lack of confidence, others as routine diversification.
Key Dates
| Date | Description |
|---|---|
| 04/01/2023 | Start date for monthly vesting of certain stock options. |
| 12/01/2025 | Date of reported stock option exercises and common stock sales. |
| 12/03/2025 | Signature date of the Form 4 filing. |
| 06/10/2029 | Expiration date for a stock option to buy 1,472 shares. |
| 02/16/2033 | Expiration date for stock options to buy 3,025 and 6,615 shares. |
Keywords
Ceribell, CBLL, Raymond Woo, CTO, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.